Provided by Tiger Trade Technology Pte. Ltd.

Lipocine

1.72
-0.2100-10.88%
Post-market: 1.730.0100+0.58%19:58 EDT
Volume:1.06M
Turnover:1.91M
Market Cap:14.18M
PE:-0.95
High:1.90
Open:1.89
Low:1.72
Close:1.93
52wk High:12.37
52wk Low:1.72
Shares:8.24M
Float Shares:6.51M
Volume Ratio:0.05
T/O Rate:16.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8181
EPS(LYR):-1.7669
ROE:-60.94%
ROA:-37.04%
PB:0.65
PE(LYR):-0.97

Loading ...

Top Midday Gainers

MT Newswires Live
·
Oct 08

U.S. Stocks on the MOVE-Halozyme, BKV, AppFolio

Reuters
·
Oct 08

Top Premarket Gainers

MT Newswires Live
·
Oct 07

Lipocine - Verity Pharma to Launch Tlando in Canada by End of 2026 - SEC Filing

THOMSON REUTERS
·
Oct 07

Lipocine - Health Canada Approves Tlando for Testosterone Replacement Therapy in Adult Males - SEC Filing

THOMSON REUTERS
·
Oct 07

Health Canada Approves Lipocine-Partnered Tlando for Testosterone Replacement Therapy

Reuters
·
Oct 07

Insiders Pile Into Lipocine, Prothena, Pampa, AFC Gamma, ASP

TIPRANKS
·
Oct 03

Lipocine Director John W. Higuchi Acquires 12,561 Common Shares Worth $27,131.76

Reuters
·
Oct 01

Lipocine Price Target Announced at $4.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: NewAmsterdam Pharma Company (NAMS) and Lipocine (LPCN)

TIPRANKS
·
Sep 22

H.C. Wainwright sets $4 price target on Lipocine

TIPRANKS
·
Sep 22

Lipocine Highlights Strategy at Global Investor Conference

TIPRANKS
·
Sep 17

Lipocine initiates Phase 3 study of LPCN 1154 for postpartum depression

TIPRANKS
·
Sep 14

Lipocine - First Participant Dosing in Bloom Study Expected in Early Q4 2026

THOMSON REUTERS
·
Sep 14

Lipocine Announces Initiation of Bloom Phase 3 Study of Lpcn 1154 for Postpartum Depression

THOMSON REUTERS
·
Sep 14

Lipocine - Expects Average Cash Use of $1 Mln Per Month During Bloom Study Execution

THOMSON REUTERS
·
Sep 14

Lipocine Initiates BLOOM Phase 3 Trial of LPCN 1154 Oral Brexanolone for Postpartum Depression

Reuters
·
Sep 14

Lipocine Raises Sales Agent Fee to up to 3% Under Equity Distribution Agreement

Reuters
·
Sep 11

Lipocine to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 10

Lipocine 8-K/A Adds Michael Grissinger to Compensation Committee

Reuters
·
Aug 22